Baytril 100 mg/ml Solution for Injection

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

Enrofloxacin

Pieejams no:

Elanco GmbH

ATĶ kods:

QJ01MA90

SNN (starptautisko nepatentēto nosaukumu):

Enrofloxacin

Deva:

100 milligram(s)/millilitre

Zāļu forma:

Solution for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības joma:

enrofloxacin

Autorizācija statuss:

Authorised

Autorizācija datums:

1988-10-01

Produkta apraksts

Health Products Regulatory Authority
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 100 mg/ml Solution for Injection
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml solution contains:
Active Substance
Enrofloxacin
100 mg
Excipients
n-butyl alcohol
30 mg
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Solution for injection.
Clear light-yellow solution.
4
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, sheep, goats and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Cattle _
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida_,
_Mannheimia _
_haemolytica _and _Mycoplasma _spp.
Treatment of acute severe mastitis caused by enrofloxacin susceptible
strains of _Escherichia coli_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of _Mycoplasma bovis _in cattle less
than 2 years old.
_Sheep _
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli. _
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus _and _Escherichia coli. _
_ _
_Goats _
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida _and
_Mannheimia haemolytica. _
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli. _
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus _and _Escherichia coli. _
_ _
_Pigs _
Treatment of infections of the resp